May 17, 2020

What three companies are dominating China's healthcare market?

3 min
What three companies are dominating China's healthcare market.jpg
Written by Alyssa Clark Today, Chinas mHealth market is estimated to be worth 1.8 billion RMB, or $291 million in the U.S., and is expected to expand...

Written by Alyssa Clark


Today, China’s mHealth market is estimated to be worth 1.8 billion RMB, or $291 million in the U.S., and is expected to expand to reach 12.5 billion by 2017. This 600 percent increase will come from breakthroughs in mHealth technology, wearables and health IT companies, like Cerner, McKesson and Epic.

As home to over 1.3 billion people, China’s healthcare sector is one that needs immediate attention and immediate investments in order to accommodate its patients’ futures. This ever-increasing demand for EMR technology, EHR, healthcare apps and healthcare IT services is set to increase by 19 percent in this year alone— marking the beginning of a long-lasting Chinese healthcare trend.

The following are the Top 3 Chinese mHealth companies to watch in 2014:

1. Microsoft and IBM pull ahead in China

These two U.S. powerhouses have managed to begin their expansion into Chinese markets, in response to a $124 billion, three-year healthcare reform plan from China’s Ministry of Health.

Microsoft has begun bracing Chinese hospitals with smart technology through the integration of EMRs, patient and bed management, laboratory data, and other patient-related data in cloud-based, real-time solutions. Microsoft has enlisted the company HealthVault to manage this integration process, in order to tie into its own EHR system as well.

IBM has installed new technology in a group of hospitals in the Guangzhou to standardize EMRs, using the collected data to statistically analyze Chinese medical treatments alongside traditional Chinese ones. This kind of accommodating technology has resonated well with the Chinese people, and they are quickly investing more in IBM’s culture-friendly procedures.

2. Apple iOS is not China’s ideal platform

In the U.S. Apple is by far the platform of choice, absorbing 43 percent of the market’s cell phones and 34 percent of the tablet market. However, in China, Apple only controls about 17 percent of the smartphone realm and 28 percent of the tablet market. This kind of comparison demonstrates just how unfavorable apples iOS capabilities in the Chinese market, and how this lapse in monopoly translates in big opportunities for investment and capitalization from its competitors.

Forbes reported that, “With IBM and Microsoft building smarter hospitals from the ground up across China, there will be less demand for native iPad EMR/EHR apps in hospitals, which were created as a response to outdated technologies in the U.S. Meanwhile, consumer-focused app developers are more likely to create health-related apps for Android to reach a wider audience.”

3. Lenovo and Microsoft becoming Chinese favorites

In order to see why Lenovo and Microsoft are huge potential investment opportunities, one needs to analyze both companies respective attempts at embracing Chinese demographics and the long-term company goals. The Motley Fool broke down the companies advantages best by listing them in the following way:

  • “Many of Lenovo's recent laptops are hybrid devices with removable tablets.
  • Most of these devices run Windows 8/8.1, which will gain market share in hospitals thanks to Microsoft's early expansion into Chinese health care IT with HealthVault.
  • Windows 8/8.1 devices are popular in hospitals, since the same EMR/EHR program can be run in both a desktop and bedside (mobile) setting, especially if the device is a hybrid with a detachable tablet.
  • Lenovo also controls 11.8% of China's fragmented smartphone market with its Android devices, putting it in third place behind Samsung and Apple. That share is poised to rise after its acquisition of Motorola earlier this year.”

Share article

Jun 22, 2021

NeuTigers: edge AI in healthcare

3 min
We take a look at edge AI and how NeuTigers is driving this forward in healthcare

What is edge AI? 

Edge AI is essentially a combination of edge computing and artificial intelligence. Algorithms are processed locally - directly on a mobile device or server - rather than in the cloud. This reduces cost, computing power and energy requirements. There are also claims that edge AI is so fast it is possible to reach near real-time analytics

Edge AI devices include smart speakers, smart phones, laptops, robots, self-driven cars, drones, and surveillance cameras that use video analytics. 

Who is NeuTigers? 

NeuTigers is a spin-off company from Princeton University, formed in 2018 to apply edge AI and machine learning to solve challenges in healthcare, energy, productivity, and security. 

With offices in Princeton, NJ, the company is based at one of the top AI accelerator programs of FutureLabs in New York, and has also established a subsidiary in Nice, France.

How is NeuTigers applying edge AI to healthcare? 

The NeuTigers AI Technology Stack uses deep  neural networks that mimic how the human brain perceives and interprets the world. The company has developed the StarDeepTM Smart Health Platform for health monitoring and biomedical imaging, to improve the accuracy and speed of diagnosing diseases. 

NeuTigers say the platform has the potential to monitor and screen for thousands of conditions,  when used in combination with medical devices and  smart sensors already deployed in healthcare settings. 

Are there any real world examples? 

In January NeuTigers launched CovidDeep, a tool that predicts COVID-19 with more than 90% accuracy, using physiological data from a wristband along with blood pressure and blood oxygen readings. It then analyses the data and gives a prediction within two minutes. 

This week NeuTigers announced a new study to detect the early signs of  complications with sickle cell anaemia.  Conducted at a hospital in Paris, the research will begin by looking at changes to skin response, heart beat, sleep and temperature to predict an acute episode of sickle cell anaemia, and how this impacts on the patients’ disease conditions and quality of life. 

The second phase of the project is to expand with prospective studies across different sites in EU, Africa  and the US to explore the models' accuracy and clinical effectiveness. 

They say...

Adel Laoui, CEO and founder of NeuTigers, says: “The best way to deal with a crisis is to avoid it happening in the first place. We are now entering a new era where medical early warning systems have become a reality. 

“We are excited at the possibility of deploying a technology that can save lives of patients dealing with sickle cell anaemia. The potential of the StarDeep platform to dramatically improve patient outcomes while slashing some of the highest costs of healthcare makes it one of the most exciting developments in preventative personal medicine.”

Share article